Advanced search
Publication Cover
Climacteric Volume 20, 2017 - Issue 3
Submit an article Journal homepage
305
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Hormone therapy for premature ovarian insufficiency patients with malignant hematologic diseases

X. YangDepartment of Obstetrics and Gynecology, Peking University People’s Hospital, Beijing, China; Correspondence[email protected]
,
C. WangDepartment of Obstetrics and Gynecology, Peking University People’s Hospital, Beijing, China;
,
X. HeDepartment of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China;
,
J. WeiDepartment of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China;
,
Y. WangDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China;
,
X. LiDepartment of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China;
&
L-P. XuBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University Institute of Hematology, People’s Hospital, Beijing, China
 show all
Pages 268-273 | Received 19 Dec 2016, Accepted 16 Mar 2017, Published online: 11 Apr 2017

References

  • Cordts EB, Christofolini DM, Dos Santos AA, Bianco B, Barbosa CP. Genetic aspects of premature ovarian failure: a literature review. Arch Gynecol Obstet 2011;283:635–43
  • Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 2008;68:499–509
  • Rebar RW. Premature ovarian failure. Obstet Gynecol 2009;113:1355–63
  • Shelling AN. Premature ovarian failure. Reproduction 2010;140:633–41
  • De VM, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010;376:911–21
  • Kodaman PH. Early menopause: primary ovarian insufficiency and surgical menopause. Semin Reprod Med 2010;28:360–9
  • Lu DP, Dong L, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006;107:3065–73
  • Wang Y, Liu QF, Xu LP, et al. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood 2015;125:3956–62
  • Keilholz U, Korbling M, Fehrentz D, Bauer H, Hunstein W. Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders. Cancer 1989;64:641–5
  • Chatterjee R, Mills W, Katz M, McGarrigle HH, Goldstone AH. Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients. Bone Marrow Transplant 1994;13:511–17
  • Grigg AP, McLachlan R, Zaja J, Szer J. Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg). Bone Marrow Transpl 2000;26:1089–95
  • Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87:3045–52
  • The 2012 Hormone Therapy Position Statement of The North American Menopause Society. Menopause 2012;19:257–71
  • Tian YXLCH. [Report on fertility in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and literature review.]. J Clin Hematol (Chinese) 2014;27:199–202
  • MacDougall LA, Barzilay JI, Helmick CG. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years. J Womens Health Gend Based Med 1999;8:1203–11
  • Ying YQML. Analysis of climacteric symptoms of perimenopausal women in Beijing city. J Reprod Drug 2008;17:329–34
  • Wang Y, Yang X, Li X, He X, Zhao Y. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey. Menopause 2014;21:1190–6
  • Ross JA, Sinner PJ, Blair CK, Cerhan JR, Folsom AR. Hormone replacement therapy is not associated with an increased risk of leukemia (United States). Cancer Causes Control 2005;16:483–8
  • Hinds L, Price J. Menopause, hormone replacement and gynaecological cancers. Menopause Int 2010;16:89–93
  • King J, Wynne CH, Assersohn L, Jones A. Hormone replacement therapy and women with premature menopause-a cancer survivorship issue. Eur J Cancer 2011;47:1623–32
  • Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917–31
  • Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2500–10
  • Peccatori FA, Azim HA, Jr., Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(Suppl 6):vi160–70
  • Blumenfeld Z, Avivi I, Eckman A, Epelbaum R, Rowe JM, Dann EJ. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 2008;89:166–73
  • Cheng YC, Takagi M, Milbourne A, Champlin RE, Ueno NT. Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients. Oncologist 2012;17:233–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.